Latest Breaking News On - Vanderbilt university or medical center - Page 1 : vimarsana.com

A US neuroscientist claims that some of the studies of the experimental agent, Simufilam, a drug that targets amyloid beta in Alzheimer s disease, are flawed and has taken his concerns to the NIH.

Charles pillerSylvain lesneKaren asheMatthew schragSylvain lesnVanderbilt university medical centerLesne laboratoryNational institutes of healthSimufilam cassava sciencesVanderbilt university in nashvilleVanderbilt university or medical centerCassava sciencesUniversity of minnesotaNational institutesVanderbilt universityMedscape medical